To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ACTR2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
419 representative clones for gene ACTR2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001005386.2   .a 1 to 3932 1 to 3932 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3932/3932
(100 %)
0 diff
(100 %id)
DC324653 brain .a 41 to 612 1 to 573   tiling clone,   573/573
(100 %)
2 diff
(99.7 %id)
DC309209 cerebellum .a 91 to 645 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BX491447   .a 97 to 723 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
DB483381 hippocampus .a 98 to 557 1 to 460       460/460
(100 %)
0 diff
(100 %id)
DC308720 cerebellum .a 117 to 662 1 to 546       546/546
(100 %)
0 diff
(100 %id)
BX472307   .a 130 to 311 1 to 182       182/182
(100 %)
0 diff
(100 %id)
DA102277 cerebellum .a 138 to 702 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA108670 cerebellum .a 140 to 726 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BX649080 Liver .a 143 to 2826 1 to 2684 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2684/2684
(100 %)
6 diff
(99.8 %id)
DN991483 brain, whole brain .a 146 to 767 16 to 638   tiling clone,   623/638
(97 %)
6 diff
(99.1 %id)
CN291265 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 150 to 353 1 to 204       204/204
(100 %)
0 diff
(100 %id)
DB219652 trachea .a 434 to 986 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
TI_154165896   .a 451 to 917 80 to 546       467/467
(100 %)
0 diff
(100 %id)
EH312865   .a 482 to 540 1 to 59       59/59
(100 %)
0 diff
(100 %id)
DA407727 thalamus .a 485 to 1022 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BP241225 Liver .a 494 to 1058 1 to 565       565/565
(100 %)
0 diff
(100 %id)
TI_154152876   .a 516 to 1173 82 to 736       655/658
(99 %)
16 diff
(97.6 %id)
DA873278 Prostate .a 525 to 1090 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA370194 thalamus .a 551 to 1095 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
TI_154153333   .a 575 to 1181 80 to 686       607/607
(100 %)
0 diff
(100 %id)
BU170460 eye, retinoblastoma .a 576 to 1350 1 to 787       787/819
(96 %)
21 diff
(97.5 %id)
BQ063077 lymph, lymphoma, cell line .a 654 to 1579 1 to 949   tiling clone,   949/1060
(89 %)
25 diff
(97.7 %id)
BM452012 eye, retinoblastoma .a 700 to 1420 1 to 728       728/924
(78 %)
19 diff
(98.0 %id)
BU429333 lymph .a 734 to 1206 8 to 480     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 473/480
(98 %)
6 diff
(98.8 %id)
BU150174 dorsal root ganglia .a 757 to 1588 1 to 835       835/837
(99 %)
5 diff
(99.5 %id)
BU184246 eye, retinoblastoma .a 778 to 1654 1 to 881   tiling clone,   881/881
(100 %)
5 diff
(99.5 %id)
TI_154168343   .a 852 to 1515 79 to 750       672/865
(77 %)
15 diff
(98.3 %id)
BF325851 amnion_normal .a 874 to 1044 1 to 171       171/171
(100 %)
0 diff
(100 %id)
BU183281 melanotic melanoma, skin .a 1074 to 1923 1 to 854       854/855
(99 %)
14 diff
(98.4 %id)
TI_57229334   .a 1082 to 1807 92 to 821       730/730
(100 %)
12 diff
(98.4 %id)
BQ216181 large cell carcinoma, lung .a 1150 to 2035 1 to 893       893/896
(99 %)
14 diff
(98.5 %id)
AW576167 lymph .a 3450 to 3932 500 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 483/484
(99 %)
0 diff
(100 %id)
NM_005722.3   .b 1 to 3917 1 to 3917 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3917/3917
(100 %)
0 diff
(100 %id)
DC404298 testis .b 1 to 551 1 to 551   tiling clone,   551/551
(100 %)
0 diff
(100 %id)
DC422815 uterus .b 40 to 585 1 to 547       547/547
(100 %)
3 diff
(99.5 %id)
DC321515 brain .b 41 to 575 1 to 538       538/538
(100 %)
3 diff
(99.5 %id)
DC323643 brain .b 42 to 646 1 to 607       607/607
(100 %)
2 diff
(99.7 %id)
DC322023 brain .b 47 to 551 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
DC341821 thalamus .b 47 to 617 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
DC420840 uterus .b 47 to 619 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DC322165 brain .b 55 to 510 1 to 456       456/456
(100 %)
0 diff
(100 %id)
DC324527 brain .b 55 to 645 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BX506783 Liver .b 58 to 615 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
DC323006 brain .b 62 to 599 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
DC306990 cerebellum .b 63 to 618 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DC377250 brain .b 63 to 587 1 to 525       525/525
(100 %)
0 diff
(100 %id)
DC423983 uterus .b 67 to 648 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB497791 hypothalamus .b 70 to 564 1 to 494       494/501
(98 %)
4 diff
(99.3 %id)
TI_44344570   .b 70 to 702 90 to 722       633/722
(87 %)
8 diff
(98.9 %id)
DC317095 amygdala .b 87 to 650 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DC350504 brain .b 88 to 663 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
DC299082   .b 90 to 660 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC309440 cerebellum .b 90 to 655 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DC347799 tongue, tumor tissue .b 90 to 665 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
DC365652   .b 90 to 640 1 to 551       551/551
(100 %)
0 diff
(100 %id)
AL706073 human skeletal muscle .b 91 to 617 1 to 527       527/527
(100 %)
0 diff
(100 %id)
DC334227 hippocampus .b 94 to 652 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
DC323894 brain .b 101 to 634 1 to 536       536/536
(100 %)
3 diff
(99.5 %id)
DC363271   .b 101 to 640 1 to 542       542/542
(100 %)
3 diff
(99.5 %id)
DC323354 brain .b 102 to 680 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BJ996500 hepatoblastoma .b 102 to 523 1 to 422       422/422
(100 %)
0 diff
(100 %id)
DC382100 placenta .b 102 to 670 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC299052   .b 103 to 663 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
DC320440 brain .b 103 to 659 1 to 557       557/557
(100 %)
0 diff
(100 %id)
AL710875 human skeletal muscle .b 103 to 712 1 to 610       610/610
(100 %)
0 diff
(100 %id)
DC296126 synovial membrane tissue from rheumatioidarthritis .b 103 to 494 1 to 393       393/399
(98 %)
4 diff
(99.0 %id)
DC423124 uterus .b 103 to 643 1 to 541       541/541
(100 %)
0 diff
(100 %id)
DC324014 brain .b 104 to 701 1 to 598       598/598
(100 %)
0 diff
(100 %id)
DC359335 lung .b 104 to 664 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
DC375608 brain .b 104 to 634 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
CR992568 T-Lymphocytes .b 104 to 751 1 to 648       648/648
(100 %)
0 diff
(100 %id)
DC321163 brain .b 105 to 646 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
DC335207 hippocampus .b 105 to 690 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BM801972 eye, retinoblastoma .b 105 to 1095 1 to 998       998/1080
(92 %)
24 diff
(97.8 %id)
DC360107   .b 105 to 615 1 to 511       511/511
(100 %)
0 diff
(100 %id)
DC348177 tongue, tumor tissue .b 106 to 617 1 to 512       512/512
(100 %)
0 diff
(100 %id)
TI_154152037   .b 106 to 582 86 to 562       477/477
(100 %)
9 diff
(98.2 %id)
DC322808 brain .b 108 to 634 1 to 528       528/528
(100 %)
1 diff
(99.9 %id)
DC423871 uterus .b 108 to 689 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
DC315365 amygdala .b 109 to 634 8 to 534       527/527
(100 %)
1 diff
(99.9 %id)
DB483051 hippocampus .b 116 to 618 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
DC408397 thymus .b 116 to 659 1 to 545       545/545
(100 %)
3 diff
(99.5 %id)
DC346471 tongue, tumor tissue .b 117 to 688 1 to 572       572/572
(100 %)
0 diff
(100 %id)
AL701801 human skeletal muscle .b 117 to 671 1 to 555       555/555
(100 %)
0 diff
(100 %id)
CN482276 eye .b 117 to 752 1 to 636       636/636
(100 %)
0 diff
(100 %id)
DC378160   .b 117 to 670 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DC382419 placenta .b 117 to 680 1 to 566       566/566
(100 %)
3 diff
(99.5 %id)
DC295902 synovial membrane tissue from rheumatioidarthritis .b 117 to 687 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
DC407823 thymus .b 117 to 675 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BX957031   .b 118 to 760 1 to 643       643/643
(100 %)
0 diff
(100 %id)
AU131915   .b 118 to 904 2 to 786   capped   785/787
(99 %)
4 diff
(99.5 %id)
DC333486 hippocampus .b 121 to 693 1 to 573       573/573
(100 %)
0 diff
(100 %id)
TI_154168787   .b 128 to 800 78 to 755       678/907
(74 %)
17 diff
(98.2 %id)
CN291282 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 129 to 781 1 to 653       653/653
(100 %)
0 diff
(100 %id)
AW499985 lymph .b 129 to 628 7 to 506       500/506
(98 %)
0 diff
(100 %id)
DC381408 placenta .b 129 to 670 1 to 545       545/545
(100 %)
3 diff
(99.5 %id)
TI_154154121   .b 129 to 786 78 to 735       658/661
(99 %)
13 diff
(98.1 %id)
DC423319 uterus .b 129 to 653 1 to 526       526/526
(100 %)
3 diff
(99.5 %id)
BX506549 Liver .b 130 to 689 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DB480990 hippocampus .b 131 to 404 1 to 274       274/274
(100 %)
0 diff
(100 %id)
DB483859 hippocampus .b 131 to 622 1 to 493       493/494
(99 %)
3 diff
(99.4 %id)
DC377092 brain .b 131 to 680 1 to 550       550/550
(100 %)
0 diff
(100 %id)
DC377312 brain .b 131 to 691 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC425581   .b 131 to 680 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DC408794 thymus .b 131 to 663 1 to 532       532/532
(100 %)
0 diff
(100 %id)
BU175810 embryonal carcinoma, cell line, testis .b 132 to 1000 1 to 870       870/875
(99 %)
2 diff
(99.8 %id)
BQ424114 melanotic melanoma, skin .b 132 to 876 1 to 748       748/809
(92 %)
5 diff
(99.4 %id)
DC377300 brain .b 132 to 670 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
DC388319 small intestine .b 132 to 703 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC391848 Spleen .b 132 to 687 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DC408421 thymus .b 132 to 587 1 to 456       456/456
(100 %)
0 diff
(100 %id)
DC420117 uterus .b 132 to 680 1 to 549       549/549
(100 %)
0 diff
(100 %id)
DC316430 amygdala .b 133 to 522 1 to 394       394/394
(100 %)
4 diff
(99.0 %id)
DC317191 amygdala .b 133 to 538 1 to 406       406/406
(100 %)
0 diff
(100 %id)
BX646626   .b 133 to 711 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC408071 thymus .b 133 to 679 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC415842 trachea .b 133 to 695 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
DC355754   .b 134 to 689 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
DC362351 Kidney .b 134 to 691 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC408719 thymus .b 134 to 663 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BC014546 skeletal muscle .b 135 to 1756 1 to 1622 M67T G172S tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1622/1622
(100 %)
9 diff
(99.5 %id)
BX646697   .b 137 to 686 1 to 550       550/550
(100 %)
0 diff
(100 %id)
DA287026 corpus callosum .b 138 to 699 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA396251 thalamus .b 138 to 716 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA416865 thalamus .b 138 to 612 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
DA446520 tongue, tumor tissue .b 138 to 729 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BX485727   .b 138 to 713 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BX957065   .b 138 to 821 1 to 684       684/684
(100 %)
0 diff
(100 %id)
DA709977   .b 138 to 673 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA826171 pericardium .b 138 to 703 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA860868 placenta .b 138 to 709 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA885223   .b 138 to 699 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB216698 trachea .b 138 to 664 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA206137 brain .b 140 to 721 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA211965 brain .b 140 to 703 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA386345 thalamus .b 140 to 719 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA647615   .b 140 to 637 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
DB286821 uterus .b 140 to 696 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA144368 amygdala .b 141 to 680 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA293230 hippocampus .b 141 to 445 2 to 306   capped   305/310
(98 %)
1 diff
(99.7 %id)
AF006082   .b 142 to 2822 1 to 2681 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 2681/2681
(100 %)
8 diff
(99.8 %id)
BM476163 duodenal adenocarcinoma, cell line, small intestine .b 142 to 1095 1 to 963       963/1069
(90 %)
27 diff
(97.5 %id)
BX956354   .b 143 to 588 1 to 446       446/446
(100 %)
0 diff
(100 %id)
CN291258 embryonic stem cells, DMSO-treated H9 cellline .b 145 to 852 1 to 709       709/709
(100 %)
2 diff
(99.8 %id)
DA426189 colon .b 146 to 704 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BM450277 eye, retinoblastoma .b 146 to 1074 1 to 938       938/992
(94 %)
10 diff
(99.0 %id)
DA861542 placenta .b 146 to 397 2 to 253   capped   252/252
(100 %)
0 diff
(100 %id)
DB215578 trachea .b 146 to 694 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB215690 trachea .b 146 to 702 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA815833   .b 147 to 712 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB171610 kidney, tumor tissue .b 147 to 718 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB233699 trachea .b 148 to 697 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA578131   .b 149 to 694 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA993539 synovial membrane tissue from rheumatioidarthritis .b 149 to 715 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA994880 synovial membrane tissue from rheumatioidarthritis .b 150 to 699 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
TI_154153725   .b 150 to 650 82 to 582       501/501
(100 %)
6 diff
(98.9 %id)
DB198296 trachea .b 150 to 732 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
CN291247 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 151 to 839 1 to 689       689/689
(100 %)
0 diff
(100 %id)
CN291291 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 151 to 677 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BX644605   .b 151 to 818 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BU542055 carcinoma, cell line, Prostate .b 151 to 987 1 to 844       844/879
(96 %)
8 diff
(99.1 %id)
AK315205 tongue, tumor tissue .b 152 to 1400 1 to 1249 exact     1249/1249
(100 %)
0 diff
(100 %id)
CN483189 eye .b 152 to 763 1 to 612       612/612
(100 %)
0 diff
(100 %id)
DA227403 brain .b 153 to 694 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA393441 thalamus .b 153 to 737 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA459879 tongue, tumor tissue .b 153 to 714 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA654972   .b 153 to 716 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA724022   .b 153 to 663 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
DB230126 trachea .b 153 to 750 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA300508 hippocampus .b 154 to 729 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA373692 thalamus .b 154 to 701 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
CN291286 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 154 to 869 1 to 716       716/716
(100 %)
0 diff
(100 %id)
DA463023   .b 154 to 711 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA796790 brain .b 154 to 695 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA806489 brain .b 154 to 707 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA884290   .b 154 to 705 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA889266   .b 154 to 710 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB209177 trachea .b 154 to 634 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DB226923 trachea .b 154 to 735 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DB237278 trachea .b 154 to 421 2 to 269   capped   268/268
(100 %)
0 diff
(100 %id)
DA034091   .b 155 to 689 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BP346190 synovial membrane .b 156 to 734 1 to 579       579/579
(100 %)
0 diff
(100 %id)
AL701323 human skeletal muscle .b 157 to 562 1 to 406       406/406
(100 %)
0 diff
(100 %id)
CN291276 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 159 to 657 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BX346070   .b 159 to 1014 1 to 855       855/855
(100 %)
3 diff
(99.7 %id)
BQ691084 ductal carcinoma, cell line, Pancreas .b 159 to 1041 1 to 894       894/899
(99 %)
12 diff
(98.7 %id)
TI_154149658   .b 162 to 683 76 to 597       522/522
(100 %)
12 diff
(97.8 %id)
TI_154154249   .b 162 to 803 79 to 719       641/642
(99 %)
5 diff
(99.3 %id)
TI_154161747   .b 162 to 724 74 to 636       563/564
(99 %)
7 diff
(98.8 %id)
TI_154165139   .b 162 to 653 79 to 570       492/492
(100 %)
11 diff
(97.8 %id)
CV572770 cornea, eye .b 164 to 800 1 to 637       637/638
(99 %)
0 diff
(100 %id)
CN291281 embryonic stem cells, DMSO-treated H9 cellline .b 168 to 825 1 to 658       658/658
(100 %)
1 diff
(99.9 %id)
AA852783 Bone, Hip .b 168 to 472 5 to 309       305/309
(98 %)
6 diff
(98.1 %id)
CN291263 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 170 to 803 1 to 634       634/639
(99 %)
2 diff
(99.7 %id)
BP250551 hippocampus .b 178 to 759 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG938578 Bone, Hip .b 180 to 841 8 to 669       662/669
(98 %)
8 diff
(98.9 %id)
DA993315 synovial membrane tissue from rheumatioidarthritis .b 180 to 716 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BQ420959 embryonal carcinoma, cell line, testis .b 181 to 1045 1 to 867       867/879
(98 %)
13 diff
(98.6 %id)
CX872123 embryonic stem .b 181 to 972 1 to 792       792/792
(100 %)
0 diff
(100 %id)
BP284611 bone marrow .b 183 to 799 1 to 617       617/617
(100 %)
0 diff
(100 %id)
TI_154154472   .b 185 to 834 80 to 729       650/650
(100 %)
4 diff
(99.4 %id)
TI_154160839   .b 185 to 755 84 to 654       571/571
(100 %)
4 diff
(99.3 %id)
TI_154157739   .b 194 to 803 80 to 688       609/619
(98 %)
11 diff
(98.3 %id)
TI_154166444   .b 194 to 1005 90 to 904       813/817
(99 %)
22 diff
(97.4 %id)
TI_154148961   .b 210 to 927 15 to 726       712/728
(97 %)
16 diff
(97.9 %id)
TI_1948093474   .b 218 to 694 132 to 608   fully sequenced,   477/608
(78 %)
10 diff
(98.4 %id)
TI_154150725   .b 218 to 948 123 to 852       730/790
(92 %)
26 diff
(96.8 %id)
BU186139 eye, retinoblastoma .b 226 to 1034 1 to 816       816/829
(98 %)
10 diff
(98.8 %id)
TI_154164878   .b 261 to 871 77 to 687       611/835
(73 %)
21 diff
(97.5 %id)
CN291256 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 262 to 846 1 to 585       585/585
(100 %)
0 diff
(100 %id)
CV322286 marrow .b 267 to 592 62 to 395       334/397
(84 %)
24 diff
(94.0 %id)
CF136529 lymph .b 297 to 678 8 to 389       382/389
(98 %)
6 diff
(98.5 %id)
TI_154165601   .b 297 to 786 80 to 570       491/948
(51 %)
18 diff
(98.2 %id)
TI_154150726   .b 346 to 946 206 to 806       599/868
(69 %)
29 diff
(96.7 %id)
TI_1948093475   .b 633 to 1399 888 to 122   fully sequenced,   767/888
(86 %)
2 diff
(99.8 %id)
AW576297 lymph .b 1654 to 2076 440 to 18   AAA   423/430
(98 %)
0 diff
(100 %id)
BJ996501 hepatoblastoma .b 1708 to 2109 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AU153571   .b 2267 to 2822 558 to 1       558/559
(99 %)
10 diff
(98.3 %id)
AK295157 brain .c 1 to 1757 1 to 1757 W37R R206I R298G tiling clone,   1757/1757
(100 %)
5 diff
(99.8 %id)
DC325096 brain .c 1 to 460 1 to 460       460/460
(100 %)
0 diff
(100 %id)
DC308627 cerebellum .c 44 to 630 1 to 587   tiling clone,   587/587
(100 %)
0 diff
(100 %id)
DC360048   .d 1 to 560 1 to 561   tiling clone,   561/561
(100 %)
1 diff
(99.9 %id)
DC426156   .d 2227 to 2764 538 to 1   tiling clone,   538/538
(100 %)
1 diff
(99.9 %id)
AK301634 esophagus, tumor tissue .e 1 to 1406 1 to 1406 I231V E263K tiling clone,   1406/1406
(100 %)
2 diff
(99.9 %id)
DC393764 esophageal, tumor tissue .e 1 to 554 1 to 554       554/554
(100 %)
0 diff
(100 %id)
AI363935 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1400 to 1527 162 to 35   tiling clone, AAA   128/139
(92 %)
0 diff
(100 %id)
BP261667 small intestine .f 1 to 553 1 to 553 exact tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
DC322583 brain .g 1 to 559 1 to 561   tiling clone,   561/561
(100 %)
2 diff
(99.7 %id)
DC308464 cerebellum .g 44 to 620 1 to 578   tiling clone,   578/578
(100 %)
1 diff
(99.9 %id)
DC324015 brain .g 69 to 642 1 to 574       574/574
(100 %)
0 diff
(100 %id)
DA225607 brain .g 98 to 663 2 to 568 exact tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
AL712920 human skeletal muscle .h 1 to 479 5 to 483 exact tiling clone,   483/483
(100 %)
0 diff
(100 %id)
DB133086 thymus .i-u 1 to 545 2 to 547   tiling clone, capped   546/546
(100 %)
6 diff
(99.0 %id)
BQ347796 head_neck .i-u 23 to 463 445 to 3   tiling clone,   443/452
(98 %)
0 diff
(100 %id)
BF325855 amnion_normal .i-u 248 to 414 167 to 1       167/187
(89 %)
3 diff
(98.4 %id)
CV353901 stomach .i-u 248 to 610 371 to 5     Submitted on the opposite strand 367/458
(80 %)
0 diff
(100 %id)
BG938579 Bone, Hip .i-u 256 to 789 544 to 11       534/544
(98 %)
0 diff
(100 %id)
BF898421 marrow .i-u 268 to 537 270 to 1     Submitted on the opposite strand 270/270
(100 %)
2 diff
(99.3 %id)
AW813164 stomach .i-u 292 to 625 344 to 12       333/344
(96 %)
0 diff
(100 %id)
CN484979 eye .i-u 334 to 969 1 to 636   tiling clone,   636/636
(100 %)
0 diff
(100 %id)
BE926166 breast_normal .i-u 360 to 576 225 to 12       214/230
(93 %)
0 diff
(100 %id)
BE926171 breast_normal .i-u 360 to 576 234 to 16       219/240
(91 %)
0 diff
(100 %id)
BF332790 breast .i-u 360 to 576 237 to 20       218/242
(90 %)
0 diff
(100 %id)
BE926178 breast_normal .i-u 378 to 576 200 to 3       198/201
(98 %)
0 diff
(100 %id)
BQ215528 melanotic melanoma, skin .i-u 450 to 1316 1 to 871       871/896
(97 %)
25 diff
(97.3 %id)
GD135594   .i-u 508 to 782 1 to 275   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 275/275
(100 %)
7 diff
(97.5 %id)
GD157543   .i-u 508 to 782 1 to 275   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 275/275
(100 %)
7 diff
(97.5 %id)
TI_154134017   .i-u 518 to 1100 691 to 100   AAA   592/1139
(51 %)
0 diff
(100 %id)
BU854150 testis .i-u 709 to 1415 1 to 712   tiling clone,   712/712
(100 %)
15 diff
(97.9 %id)
CX867380 embryonic stem .i-u 723 to 1423 1 to 701     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 701/701
(100 %)
2 diff
(99.8 %id)
BU618846 Cell Line, Chondrosarcoma .i-u 750 to 1340 65 to 655     Submitted on the opposite strand 591/655
(90 %)
6 diff
(99.1 %id)
ES313516 beard hair, skin .i-u 850 to 1301 1 to 453       453/453
(100 %)
3 diff
(99.4 %id)
TI_45209257   .i-u 850 to 1494 87 to 726       640/726
(88 %)
6 diff
(99.2 %id)
TI_154165377   .i-u 853 to 1495 80 to 727       648/804
(80 %)
17 diff
(97.9 %id)
DB487645 hypothalamus .i-u 856 to 1295 1 to 441       441/441
(100 %)
2 diff
(99.6 %id)
TI_57230319   .i-u 865 to 1586 87 to 806       720/721
(99 %)
27 diff
(96.3 %id)
BM552481 leiomyosarcoma, uterus .i-u 871 to 1743 1 to 880       880/967
(91 %)
13 diff
(98.7 %id)
BM454357 lymph, lymphoma, cell line .i-u 876 to 1738 1 to 879       879/1097
(80 %)
35 diff
(96.9 %id)
BM463962 melanotic melanoma, skin .i-u 881 to 1944 1 to 1072 Y9D I13X I18L E20G L21G ...     1072/1086
(98 %)
32 diff
(97.1 %id)
AW978644   .i-u 898 to 1440 543 to 1     Submitted on the opposite strand 543/602
(90 %)
6 diff
(99.1 %id)
BM458782 lymph, lymphoma, cell line .i-u 971 to 1895 1 to 926       926/1129
(82 %)
9 diff
(99.3 %id)
BQ213439 embryonal carcinoma, cell line, testis .i-u 985 to 1814 11 to 841       831/841
(98 %)
6 diff
(99.3 %id)
ES313134 beard hair, skin .i-u 1005 to 1122 1 to 118       118/118
(100 %)
1 diff
(99.2 %id)
TI_59393656   .i-u 1014 to 1529 111 to 626       516/563
(91 %)
12 diff
(97.9 %id)
BQ227673 brain .i-u 1016 to 1867 1 to 859       859/859
(100 %)
18 diff
(98.0 %id)
BI087481 cervix .i-u 1018 to 1869 1 to 854       854/891
(95 %)
23 diff
(97.5 %id)
BM468438 melanotic melanoma, skin .i-u 1019 to 1923 1 to 917 K11E I13N P14T F22I L23S ...     917/1045
(87 %)
23 diff
(97.8 %id)
BM462347 leiomyosarcoma, uterus .i-u 1023 to 1997 1 to 990 F22I L23S S24K L25F K26E ...     990/1009
(98 %)
27 diff
(97.4 %id)
BQ016852 lung, Lung Focal Fibrosis .i-u 1026 to 1456 8 to 438     Submitted on the opposite strand 431/438
(98 %)
6 diff
(98.7 %id)
CX870577 embryonic stem .i-u 1028 to 1825 1 to 798       798/798
(100 %)
0 diff
(100 %id)
BU188727 melanotic melanoma, skin .i-u 1029 to 1916 1 to 892 I13Y P14Q N15I S16V T17P ...     892/895
(99 %)
15 diff
(98.4 %id)
BQ438032 melanotic melanoma, skin .i-u 1029 to 1875 1 to 855       855/857
(99 %)
13 diff
(98.5 %id)
TI_57187180   .i-u 1030 to 1814 48 to 832       785/788
(99 %)
9 diff
(98.9 %id)
TI_57190684   .i-u 1030 to 1852 53 to 876       824/922
(89 %)
24 diff
(97.4 %id)
BY995267   .i-u 1030 to 1703 10 to 683       674/683
(98 %)
6 diff
(99.2 %id)
BI859390 breast, mammary adenocarcinoma, cell line .i-u 1031 to 1852 1 to 823       823/838
(98 %)
24 diff
(97.2 %id)
CX166467 human embryonic stem cells differentiated toan early endodermal cell type .i-u 1034 to 1916 1 to 880 N27S K50N L51F F53N N54*     880/880
(100 %)
5 diff
(99.5 %id)
TI_154160333   .i-u 1035 to 1577 81 to 623       543/544
(99 %)
8 diff
(98.6 %id)
AA021093 eye, retina .i-u 1043 to 1480 1 to 439     Submitted on the opposite strand 439/440
(99 %)
2 diff
(99.6 %id)
BM905915 leiomyosarcoma, uterus .i-u 1047 to 1972 1 to 936 L21F F22I L23S S24K L25F ...     936/1072
(87 %)
29 diff
(97.3 %id)
AA853693 Bone, Hip .i-u 1051 to 1230 9 to 188       180/188
(95 %)
6 diff
(96.9 %id)
BQ438021 leiomyosarcoma, uterus .i-u 1053 to 1875 1 to 831       831/843
(98 %)
24 diff
(97.2 %id)
BU145591 dorsal root ganglia .i-u 1054 to 1974 1 to 924 N27S F47L F53*     924/924
(100 %)
19 diff
(98.0 %id)
CV575292 cornea, eye .i-u 1054 to 1671 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BU181132 embryonal carcinoma, cell line, testis .i-u 1055 to 1951 1 to 895 N27S K30N L31C H32I H33T ...     895/895
(100 %)
11 diff
(98.8 %id)
BQ425220 eye, retinoblastoma .i-u 1064 to 1940 13 to 889 K11X N27K K28*     877/890
(98 %)
11 diff
(98.8 %id)
BU161312 melanotic melanoma, skin .i-u 1074 to 1932 1 to 862 N27S V40G L41S E42G I44N ...     862/863
(99 %)
10 diff
(98.9 %id)
BJ992796 hepatoblastoma .i-u 1115 to 1518 1 to 404       404/404
(100 %)
1 diff
(99.8 %id)
BY994914   .i-u 1172 to 1598 7 to 433       427/437
(97 %)
6 diff
(98.7 %id)
BM090588 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .i-u 1174 to 1720 1 to 547       547/547
(100 %)
0 diff
(100 %id)
BQ277430 mixed (pool of 40 RNAs) .i-u 1179 to 2044 1 to 872 S24K L25F K26E N27K K28*     872/911
(95 %)
20 diff
(97.9 %id)
GD147095   .i-u 1213 to 1443 1 to 231       231/235
(98 %)
5 diff
(97.9 %id)
BM090816 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .i-u 1273 to 1861 589 to 1       589/589
(100 %)
0 diff
(100 %id)
EB388005 eye, optic nerve .i-u 1287 to 2153 1 to 865 N27S F53*     865/865
(100 %)
11 diff
(98.8 %id)
CN291266 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i-u 1294 to 1809 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BF930611 nervous_tumor .i-u 1317 to 1470 163 to 13     Submitted on the opposite strand 151/163
(92 %)
0 diff
(100 %id)
BM793128 Ascites, stomach .i-u 1323 to 1743 1 to 421       421/421
(100 %)
0 diff
(100 %id)
BQ436402 embryonal carcinoma, cell line, testis .i-u 1325 to 2065 1 to 742 exact tiling clone,   742/891
(83 %)
8 diff
(99.2 %id)
BU177470 melanotic melanoma, skin .i-u 1326 to 2179 12 to 874 N27S F53*     863/875
(98 %)
27 diff
(97.0 %id)
BI859304 breast, mammary adenocarcinoma, cell line .i-u 1361 to 2153 1 to 787 exact     787/788
(99 %)
14 diff
(98.3 %id)
TI_57190772   .i-u 1361 to 2153 52 to 838 exact     787/788
(99 %)
14 diff
(98.3 %id)
Z43370 brain, total brain .i-u 1439 to 1767 1 to 329       329/329
(100 %)
0 diff
(100 %id)
AI969231 lung, two pooled squamous cell carcinomas .i-u 1451 to 1846 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AI567774 adenocarcinoma, Pancreas .i-u 1452 to 1849 398 to 1       398/398
(100 %)
0 diff
(100 %id)
AW390439 stomach .i-u 1460 to 1595 137 to 5       133/145
(91 %)
0 diff
(100 %id)
BG198417   .i-u 1465 to 1591 160 to 34   AAA Submitted on the opposite strand 127/127
(100 %)
0 diff
(100 %id)
BM990568 lung, Metastatic Chondrosarcoma .i-u 1526 to 2288 1 to 760 exact   Submitted on the opposite strand 760/760
(100 %)
6 diff
(99.3 %id)
BQ440248 melanotic melanoma, skin .i-u 1544 to 2377 12 to 853 exact     842/854
(98 %)
16 diff
(98.2 %id)
CR593126 B cells (Ramos cell line) Cot 25-normalized .i-u 1563 to 2925 1 to 1363 exact tiling clone,   1363/1363
(100 %)
0 diff
(100 %id)
BX368967   .i-u 1563 to 2364 1 to 800 exact     800/803
(99 %)
6 diff
(99.3 %id)
BX368968   .i-u 1563 to 2364 1 to 792 exact     792/833
(95 %)
27 diff
(96.8 %id)
F07902 brain, total brain .i-u 1587 to 1856 1 to 270       270/270
(100 %)
1 diff
(99.7 %id)
Z46064 brain, total brain .i-u 1588 to 1886 1 to 299       299/299
(100 %)
1 diff
(99.7 %id)
F07421 brain, total brain .i-u 1588 to 1868 1 to 281       281/281
(100 %)
0 diff
(100 %id)
F07141 brain, total brain .i-u 1589 to 1845 1 to 257       257/257
(100 %)
0 diff
(100 %id)
BU172670 melanotic melanoma, skin .i-u 1605 to 2457 1 to 857 exact     857/857
(100 %)
8 diff
(99.1 %id)
BQ775858 Bone, Human Chondrosarcoma Cell Line .i-u 1605 to 2336 1 to 730 exact   Submitted on the opposite strand 730/733
(99 %)
7 diff
(99.1 %id)
AA007317 liver and spleen .i-u 1625 to 2111 1 to 486 K11X I13X K30X     486/486
(100 %)
2 diff
(99.6 %id)
BM905663 leiomyosarcoma, uterus .i-u 1690 to 2572 1 to 890 N27S F53*     890/1049
(84 %)
40 diff
(96.2 %id)
BI089692 cervix .i-u 1749 to 2595 1 to 849       849/849
(100 %)
18 diff
(97.9 %id)
TI_154136288   .i-u 1781 to 2591 902 to 98   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 805/809
(99 %)
31 diff
(96.2 %id)
TI_154098014   .i-u 1811 to 2591 865 to 96   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 770/1105
(69 %)
21 diff
(98.1 %id)
TI_154062749   .i-u 1820 to 2591 861 to 95   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 767/959
(79 %)
12 diff
(98.8 %id)
BU616817 Cell Line, Chondrosarcoma .i-u 1833 to 2591 776 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 758/758
(100 %)
5 diff
(99.4 %id)
BQ684301 melanotic melanoma, cell line, skin .i-u 1839 to 2721 1 to 888       888/907
(97 %)
17 diff
(98.2 %id)
TI_159696550   .i-u 1844 to 2686 914 to 85   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 830/978
(84 %)
10 diff
(99.0 %id)
BU180544 epidermoid carcinoma, cell line, salivary gland .i-u 1907 to 2735 1 to 840       840/914
(91 %)
27 diff
(97.1 %id)
BQ674039 epidermoid carcinoma, cell line, salivary gland .i-u 1907 to 2834 1 to 931       931/931
(100 %)
15 diff
(98.4 %id)
CN480560 Cell Line, Chondrosarcoma .i-u 1934 to 2686 770 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 752/761
(98 %)
1 diff
(99.9 %id)
W16782 lung .i-u 1944 to 2365 1 to 414   fully sequenced,   414/414
(100 %)
2 diff
(99.6 %id)
AA047330 uterus .i-u 1946 to 2229 1 to 286   fully sequenced,   286/286
(100 %)
1 diff
(99.7 %id)
BU949350 Pancreas, Purified pancreatic islet .i-u 1963 to 2465 1 to 503   fully sequenced,   503/503
(100 %)
1 diff
(99.9 %id)
TI_149306949   .i-u 1974 to 2941 1048 to 84   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 965/966
(99 %)
17 diff
(98.3 %id)
TI_154118252   .i-u 2028 to 2934 987 to 88   AAA   900/970
(92 %)
0 diff
(100 %id)
TI_154016585   .i-u 2043 to 2941 980 to 88   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 893/970
(92 %)
31 diff
(96.9 %id)
TI_154062319   .i-u 2051 to 2935 966 to 97   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 870/930
(93 %)
22 diff
(97.7 %id)
BX374305   .i-u 2060 to 2919 872 to 7       866/873
(99 %)
0 diff
(100 %id)
BU508544 leiomyosarcoma, uterus .i-u 2082 to 2934 1 to 859       859/921
(93 %)
13 diff
(98.6 %id)
BG575101 breast, mammary adenocarcinoma, cell line .i-u 2088 to 2870 1 to 782       782/783
(99 %)
11 diff
(98.6 %id)
W48765 senescent fibroblast .i-u 2094 to 2540 1 to 448       448/448
(100 %)
6 diff
(98.7 %id)
TI_154126721   .i-u 2099 to 2941 928 to 100   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 829/924
(89 %)
16 diff
(98.3 %id)
TI_149293746   .i-u 2126 to 2941 889 to 84   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 806/949
(84 %)
16 diff
(98.4 %id)
TI_154061688   .i-u 2126 to 2941 910 to 103   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 808/965
(83 %)
15 diff
(98.5 %id)
AW169477 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i-u 2127 to 2591 465 to 1       465/465
(100 %)
0 diff
(100 %id)
DB552298 hippocampus .i-u 2134 to 2591 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
AA007453 liver and spleen .i-u 2135 to 2591 456 to 1       456/460
(99 %)
2 diff
(99.6 %id)
AI095512 uterus .i-u 2137 to 2591 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AI688242 colon .i-u 2142 to 2595 454 to 1       454/454
(100 %)
0 diff
(100 %id)
TI_154125521   .i-u 2151 to 2941 872 to 90   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 783/970
(80 %)
12 diff
(98.8 %id)
DB499885 hypothalamus .i-u 2152 to 2647 1 to 496       496/496
(100 %)
0 diff
(100 %id)
DB506266 hypothalamus .i-u 2152 to 2625 1 to 474       474/474
(100 %)
0 diff
(100 %id)
AL049356 Kidney .i-u 2153 to 2941 1 to 788   available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 788/788
(100 %)
1 diff
(99.9 %id)
TI_154131743   .i-u 2174 to 2941 865 to 102   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 764/955
(80 %)
10 diff
(99.0 %id)
BM053007 Islets of Langerhans, Pancreas .i-u 2177 to 2526 1 to 350   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 350/350
(100 %)
0 diff
(100 %id)
AI126880 heart .i-u 2178 to 2591 434 to 21   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
TI_154127945   .i-u 2193 to 2941 803 to 61   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 743/888
(83 %)
32 diff
(96.4 %id)
AA047331 uterus .i-u 2199 to 2591 393 to 1   fully sequenced,   393/393
(100 %)
0 diff
(100 %id)
TI_149304333   .i-u 2199 to 2941 798 to 56   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 743/930
(79 %)
20 diff
(97.9 %id)
CA416792 Chondrosarcoma Cell line .i-u 2209 to 2941 750 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 732/732
(100 %)
1 diff
(99.9 %id)
N50294 multiple sclerosis lesions .i-u 2210 to 2549 1 to 343   fully sequenced, AAA   343/343
(100 %)
2 diff
(99.5 %id)
BM989601 lung, Metastatic Chondrosarcoma .i-u 2211 to 2941 749 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 731/731
(100 %)
0 diff
(100 %id)
BM685630 eye, RPE and Choroid .i-u 2212 to 2882 1 to 671       671/671
(100 %)
5 diff
(99.3 %id)
BU192505 large cell carcinoma, lung .i-u 2215 to 2943 1 to 733       733/915
(80 %)
9 diff
(99.1 %id)
AI248583 liver and spleen .i-u 2218 to 2591 374 to 1       374/374
(100 %)
0 diff
(100 %id)
CA419501 Bone, Human Chondrosarcoma Cell Line .i-u 2221 to 2941 739 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 721/721
(100 %)
0 diff
(100 %id)
TI_149282082   .i-u 2226 to 2941 816 to 101   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 716/718
(99 %)
7 diff
(99.1 %id)
CA308958 Alveolar Macrophage, lung .i-u 2226 to 2941 734 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 716/716
(100 %)
2 diff
(99.8 %id)
BU682767 lung .i-u 2227 to 2941 733 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
CD365916 Alveolar Macrophage, lung .i-u 2227 to 2935 726 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 708/708
(100 %)
2 diff
(99.8 %id)
BU629480 cell lines, Chondrosarcoma .i-u 2228 to 2941 732 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 714/714
(100 %)
0 diff
(100 %id)
BU627985 Bone, Enchondroma cell line .i-u 2242 to 2941 718 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 700/700
(100 %)
0 diff
(100 %id)
BM708911 eye, RPE and Choroid .i-u 2248 to 2677 1 to 430   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
TI_149278084   .i-u 2267 to 2941 783 to 109   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 675/676
(99 %)
2 diff
(99.8 %id)
CR739267 carcinoid, lung .i-u 2270 to 2930 1 to 661   AAA   661/672
(98 %)
1 diff
(99.9 %id)
AA480334 colon .i-u 2294 to 2591 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AA505556 breast .i-u 2294 to 2590 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AI023074 senescent fibroblast .i-u 2294 to 2596 303 to 1       303/303
(100 %)
0 diff
(100 %id)
CA420766 Bone, Enchondroma cell line .i-u 2294 to 2941 666 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 648/648
(100 %)
0 diff
(100 %id)
TI_149299201   .i-u 2295 to 2941 730 to 89   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 642/768
(83 %)
12 diff
(98.5 %id)
Z40245 brain, total brain .i-u 2298 to 2591 294 to 1       294/294
(100 %)
0 diff
(100 %id)
F03430 brain, total brain .i-u 2299 to 2591 293 to 1       293/293
(100 %)
0 diff
(100 %id)
CA437300 lung, Metastatic Chondrosarcoma .i-u 2303 to 2941 658 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 640/640
(100 %)
4 diff
(99.4 %id)
F04157 brain, total brain .i-u 2305 to 2586 287 to 6       282/287
(98 %)
0 diff
(100 %id)
BM978897 lung, Primary Lung Epithelial Cells .i-u 2308 to 2941 653 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 635/635
(100 %)
1 diff
(99.9 %id)
BQ773141 Chondrosarcoma Cell line .i-u 2308 to 2941 652 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 634/634
(100 %)
0 diff
(100 %id)
BU678205 lung .i-u 2309 to 2941 651 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 633/633
(100 %)
1 diff
(99.9 %id)
BU629218 cell lines, Chondrosarcoma .i-u 2309 to 2941 651 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 633/633
(100 %)
0 diff
(100 %id)
CA421111 Bone, Enchondroma cell line .i-u 2318 to 2935 636 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 618/629
(98 %)
0 diff
(100 %id)
BQ021352 lung, Metastatic Chondrosarcoma .i-u 2330 to 2941 630 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 612/612
(100 %)
1 diff
(99.9 %id)
CA418207 Bone, Human Chondrosarcoma Cell Line .i-u 2330 to 2941 630 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 612/612
(100 %)
0 diff
(100 %id)
AI133009 Liver .i-u 2331 to 2736 236 to 642       407/413
(98 %)
6 diff
(98.6 %id)
BM989336 Fibrosarcoma .i-u 2331 to 2941 630 to 20   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 611/611
(100 %)
0 diff
(100 %id)
BU625727 cell lines, Enchondroma .i-u 2331 to 2935 623 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 605/605
(100 %)
0 diff
(100 %id)
N77834 lung .i-u 2335 to 2591 257 to 1   fully sequenced,   257/257
(100 %)
0 diff
(100 %id)
BQ019871 Chondrosarcoma, Left Pubic Bone .i-u 2342 to 2941 618 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 600/600
(100 %)
0 diff
(100 %id)
AI370329 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .i-u 2343 to 2571 229 to 1       229/229
(100 %)
0 diff
(100 %id)
TI_149284064   .i-u 2354 to 2941 689 to 101   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 589/785
(75 %)
1 diff
(99.9 %id)
CB854590 lung, Primary Lung Epithelial Cells .i-u 2354 to 2941 607 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 589/602
(97 %)
1 diff
(99.9 %id)
AI473477 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i-u 2366 to 2591 226 to 1       226/226
(100 %)
0 diff
(100 %id)
AI718624 aorta .i-u 2367 to 2941 575 to 1       575/575
(100 %)
0 diff
(100 %id)
BI962750 Islets of Langerhans, Pancreas .i-u 2394 to 2941 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
BI962614 Islets of Langerhans, Pancreas .i-u 2395 to 2863 1 to 469       469/469
(100 %)
0 diff
(100 %id)
F03651 brain, total brain .i-u 2399 to 2591 193 to 1       193/193
(100 %)
0 diff
(100 %id)
AI922125 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .i-u 2409 to 2941 533 to 1       533/533
(100 %)
0 diff
(100 %id)
AW079980 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .i-u 2433 to 2943 511 to 1   tiling clone,   511/511
(100 %)
0 diff
(100 %id)
BU949111 Pancreas, Purified pancreatic islet .i-u 2435 to 2948 514 to 1   fully sequenced,   514/514
(100 %)
6 diff
(98.9 %id)
BM975650 lung, Primary Lung Cystic Fibrosis EpithelialCells .i-u 2435 to 2941 525 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 507/507
(100 %)
0 diff
(100 %id)
AI540200 B-cell, chronic lymphotic leukemia .i-u 2438 to 2937 500 to 1       500/500
(100 %)
0 diff
(100 %id)
CX867307 embryonic stem .i-u 2444 to 2941 527 to 30   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 498/498
(100 %)
5 diff
(99.0 %id)
AW338305 adenocarcinoma, Pancreas .i-u 2452 to 2942 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AI817405 lymph node, lymphoma, follicular mixed small and largecell .i-u 2459 to 2941 496 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 483/483
(100 %)
0 diff
(100 %id)
AI753490 bone marrow stroma .i-u 2475 to 2941 485 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 467/467
(100 %)
0 diff
(100 %id)
AI753315 bone marrow stroma .i-u 2478 to 2935 486 to 29   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
DB571030 hypothalamus .i-u 2479 to 2941 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AA857591 epithelium (cell line), Prostate .i-u 2494 to 2881 388 to 1       388/388
(100 %)
0 diff
(100 %id)
BM052724 Islets of Langerhans, Pancreas .i-u 2496 to 2941 459 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
BJ992797 hepatoblastoma .i-u 2500 to 2902 405 to 1       405/405
(100 %)
2 diff
(99.6 %id)
N36158 melanocyte .i-u 2501 to 2943 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AA669863 bone marrow stroma .i-u 2516 to 2940 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AA886678 Kidney .i-u 2517 to 2941 425 to 1       425/425
(100 %)
0 diff
(100 %id)
N47082 multiple sclerosis lesions .i-u 2519 to 2936 419 to 1   fully sequenced,   419/419
(100 %)
2 diff
(99.6 %id)
AI817508 lymph node, lymphoma, follicular mixed small and largecell .i-u 2523 to 2941 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AA663066   .i-u 2531 to 2940 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AA205368   .i-u 2536 to 2943 408 to 1       408/408
(100 %)
0 diff
(100 %id)
W49784 senescent fibroblast .i-u 2540 to 2935 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
BQ775052 Bone, Human Chondrosarcoma Cell Line .i-u 2543 to 2941 417 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 399/399
(100 %)
0 diff
(100 %id)
ES314360 occipital scalp hair, skin .i-u 2611 to 2750 1 to 140       140/140
(100 %)
0 diff
(100 %id)
BM993143 lung, Metastatic Chondrosarcoma .i-u 2630 to 2941 330 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 312/312
(100 %)
0 diff
(100 %id)
AA505671 breast .i-u 2631 to 2941 326 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
BU731572 eye, RPE and Choroid .i-u 2647 to 2941 313 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 295/295
(100 %)
2 diff
(99.4 %id)
Z39440 brain, total brain .i-u 2656 to 2941 287 to 1       287/287
(100 %)
1 diff
(99.7 %id)
AI537433 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i-u 2715 to 2941 246 to 20   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 227/227
(100 %)
0 diff
(100 %id)
DA238545 brain .j-u 1 to 555 2 to 555   tiling clone, capped   554/554
(100 %)
4 diff
(99.3 %id)
AK025051 colon .j-u 240 to 2171 1 to 1932 K20E tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1932/1932
(100 %)
3 diff
(99.9 %id)
DA887190   .j-u 1187 to 1732 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
CV572358 cornea, eye .k-u 1 to 635 1 to 635   tiling clone,   635/635
(100 %)
2 diff
(99.7 %id)
AV734798 pheochromocytoma .k-u 557 to 931 1 to 379   tiling clone,   379/510
(74 %)
12 diff
(97.7 %id)
BG570844 placenta .k-u 644 to 1304 1 to 670 V2N D4W E5* tiling clone,   670/831
(80 %)
18 diff
(97.9 %id)
DC341204 thalamus .l 1 to 568 8 to 575 exact tiling clone,   575/575
(100 %)
1 diff
(99.9 %id)
229 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k-u, .l Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI